|Articles|October 16, 2019
Advancing Oncology Drug Development with ePRO Solutions
Author(s)YPrime
• Practical considerations for ePRO implementation during trials • Future of eCOA and oncology PRO instruments • Approaches for improving PRO in oncology trials
Trending on Applied Clinical Trials Online
1
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
2
From Participation to Understanding: Reframing Engagement in Clinical Trials
3
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
4
ACT Brief: RBQM Multi-Functional Buy-In and E6(R3), Site Payment Performance and Cash Runway, and Inhaled Therapy for Cystic Fibrosis
5